Skip to main content
Signal8

Huang Ying

SEC insider (Form 3/4/5 filer). CIK 0001967360. Director at ADARx Pharmaceuticals, Inc. (ADRX) and 2 other issuers. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in SAN DIEGO, CA.

Companies Huang Ying has filed insider reports for

  • ADARx Pharmaceuticals, Inc. (ADRX): Director
  • TCGX Acquisition Corp. (TCGX): Director
  • Legend Biotech Corp (LEGN): Director, Officer, Chief Executive Officer
Huang Ying profile photo

Huang Ying

CIK: 0001967360

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ADARx Pharmaceuticals, Inc. logo
ADRX

ADARx Pharmaceuticals, Inc.

Director
TCGX Acquisition Corp. logo
TCGX

TCGX Acquisition Corp.

Director
Legend Biotech Corp logo
LEGN

Legend Biotech Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Legend Biotech Corp logo
    LEGN

    Legend Biotech Corp

    Jun 30, 2026
    Gift
    Direct
    3.4K shares-
  • Legend Biotech Corp logo
    LEGN

    Legend Biotech Corp

    Jun 25, 2026
    Sale
    Direct
    5.6K shares at avg. $14.78$82K
  • Legend Biotech Corp logo
    LEGN

    Legend Biotech Corp

    Mar 25, 2026
    Sale
    Direct
    9.9K shares at avg. $8.77$87K

1-3 of 3